High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugate

Zhao, SC; Molina, A; Yu, A; Hanson, J; Cheung, H; Li, XF; Natkunam, Y

Natkunam, Y (reprint author), Stanford Univ, Sch Med, Dept Pathol, L235,300 Pasteur Dr, Stanford, CA 94305 USA.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019; 5 (1): 12

Abstract

CD74 is a type II transmembrane glycoprotein that functions as an MHC class II chaperone and displays diverse roles in immune responses. Recently, ant......

Full Text Link